OPHTHALMIC VISCOELASTIC DEVICES MARKET ANALYSIS

Ophthalmic Viscoelastic Devices Market, by Product Type (Dispersive Ophthalmic Viscoelastic Devices, and Cohesive Ophthalmic Viscoelastic Devices), by Application (Cataract Surgery, Glaucoma Surgery, Vitreoretinal Surgery, Corneal Transplantation Surgery, and Others), by Composition (Sodium Hyaluronate, Chondroitin Sulfate, and Hydroxypropyl Methylcellulose), by End User (Ophthalmic Clinics, Hospitals, and Academic and Research Institutes), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

Published In : Dec 2019
Code : CMI2521
Pages :209
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

Increasing product recalls is expected to hamper the global ophthalmic viscoelastic devices market growth

Product recalls for ophthalmic viscoelastic devices is expected to negatively impact the market growth. In November 2014, the U.S. FDA issued a product recall notice for Abbott Healon EndoCoat Ophthalmic Viscosurgical Device, developed by Abbott Medical Optics Inc. (AMO). The device was recalled due to finger grip dislodgement of the device which could result in unintentional movement of the surgeon's hand to the surface of the cannula and cause potential trauma to the eye. Product recalls due to mechanical defects in ophthalmic viscoelastic devices is projected to generate losses for manufacturers in terms of cost and time, and hinder growth of the global ophthalmic viscoelastic devices market.